Guinea vs Jordan: Access to anti-retroviral drugs, male
Guinea
64.0%
in 2024
Jordan
64.0%
in 2024
Guinea rank
87th
Jordan rank
87th
Access to anti-retroviral drugs, male over time
- Guinea
- Jordan
How they compare
Guinea currently reports 64.0% against 64.0% in Jordan, a difference of 0.0%.
The two have swapped places 2 times across 25 shared years of data; in 2000 it was Jordan ahead.
Guinea ranks 87th and Jordan ranks 87th of 141 countries.
Jordan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.6% | 20.6% | 16.0% | Jordan |
| 2010s | 26.9% | 42.9% | 16.0% | Jordan |
| 2020s | 51.2% | 53.8% | 2.6% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Guinea or Jordan?
- Guinea, at 64.0% against 64.0% in Jordan as of 2024.
- What is the difference in access to anti-retroviral drugs, male between Guinea and Jordan?
- 0.0%, with Guinea ahead.
- How many years of comparable data are there for Guinea and Jordan?
- 25 years are reported by both, from 2000 to 2024.
- How do Guinea and Jordan rank globally for access to anti-retroviral drugs, male?
- Guinea ranks 87th and Jordan ranks 87th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.